Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rossmax InternationalROCO:4121 -0.76%55 OCF Margin % is 4.29% as of Mar. 2026, which is 44% below its 10-year median of 7.71. GuruFocus rates ROCO:4121 with a GF Score™ of 55/100 and a GF Value™ of NT$18.19 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Rossmax International ranks better than 53.01% on this metric.
The historical rank and industry rank for Rossmax International's OCF Margin % or its related term are showing as below:
ROCO:4121'
s OCF Margin % Range Over the Past 10 Years
Min: -3.09 Med: 7.71 Max: 14.58
Current: 7.33
During the past 13 years, the highest OCF Margin % of Rossmax International was 14.58%. The lowest was -3.09%. And the median was 7.71%.
ROCO:4121's OCF Margin % is ranked better than 53.01% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.57
vs ROCO:4121: 7.33
Rossmax International OCF Margin % Historical Data
* Premium members only.
The historical data trend for Rossmax International's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4121 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Rossmax International's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossmax International OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Rossmax International's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossmax International (ROCO:4121) has a OCF Margin % of 4.29% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rossmax International and its competitors. This is 44% below median its historical median of 7.71. According to the industry distribution chart, Rossmax International ranks #383 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 47%.
Is Rossmax International's OCF Margin % too high?
Rossmax International's current OCF Margin % of 4.29% is 44% below median its 10-year median of 7.71. The Medical Devices & Instruments industry median OCF Margin % is 5.57. Rossmax International's value of 4.29% is 23% below this industry median. Based on the distribution chart, Rossmax International ranks #383 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Rossmax International has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #383 out of 815 companies for OCF Margin %. This puts Rossmax International in the upper half of its industry. The industry median OCF Margin % is 5.57. Rossmax International's value of 4.29% is 23% below this benchmark. While the company's 10-year median is 7.71 vs. the industry median of 5.57, Rossmax International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.57, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossmax International's current OCF Margin % of 4.29% is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rossmax International and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossmax International's current OCF Margin % is 4.29%, which is 44% below median its own 10-year median of 7.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$18.19, compared to a current price of NT$13.00 — trading 28.5% below its estimated fair value. The current OCF Margin % is 4.29%, which is 44% below median its 10-year median of 7.71 and 23% below the Medical Devices & Instruments industry median of 5.57. Rossmax International's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current OCF Margin % is 4.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossmax International (ROCO:4121) Overvalued in 2026?
Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued.
The current stock price of NT$13.00 is trading 28.5% below its estimated GF Value™ of NT$18.19.
GuruFocus considers Rossmax International to be Modestly Undervalued.
Key valuation signals for ROCO:4121:
OCF Margin %: 4.29% (44% below median its 10-year median of 7.71)
GF Value™: NT$18.19 vs. price of NT$13.00 (28.5% below fair value)
Industry Position: 23% below the Medical Devices & Instruments median (#383 of 815)
No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
55GF Score
Get the complete analysis for ROCO:4121
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4121 has been successfully added to your 
